Subspecialties

A patient has undergone a premium refractive cataract procedure, and they’re unhappy. How are you going to fix it?

Sitting Down With... Zoltán Nagy, Head of the Department of Clinical Ophthalmology and the Institute of Health Diagnostics, Dean of the Faculty of Health Sciences, and Director of the Department of Ophthalmology at Semmelweis University, Budapest, Hungary

Swiss researchers have developed methods for performing corneal crosslinking with riboflavin and corneal biomechanical testing in mice – opening up the world of transgenics and molecular testing.

Dichoptic films could offer a new and engaging treatment method for children with amblyopia

Vaccination complications as an explanation for retinal hemorrhage in children should not be accepted clinically or legally, new study data suggests

IOL power calculation formulae all have their own strengths and weaknesses – so researchers decided to combine those strengths into a single “super formula”

Using a mouse model to shed new light on a genetic cause of enlarged eyeballs

Vasotide, a small molecule that stops VEGF binding to endothelial receptor molecules, has shown promise in animal models and can be delivered using eyedrops

U.K. Ophthalmologists are the leading adopters of Oraya Therapy for the treatment of wet age-related macular degeneration (AMD), two years after the treatment was introduced in the country.

Anti-VEGF monotherapy may not be adequate for all your wet AMD patients. The Oraya Therapy™ Stereotactic Radiotherapy for Wet AMD, intended as a one-time treatment, has been shown to maintain vision while reducing the number of anti-VEGF injections, providing a viable option for patients with significant fluid in the macula.